Skip to main content
OpenTrials
Completed

NCT Number: NCT00870597

Transconjunctival Sutureless 25-Gauge Vitrectomy

The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Visual Acuity vitreous floaters

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Hospital Oftalmologico de Brasilia

Brasília, Federal District, 70000, Brazil

About this study

Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Setting: Hospital Oftalmológico de Brasília, Brasília, DF, Brazil.

Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • disabling vitreous floaters
  • Age-related cataract Unsatisfactory correction with glasses

Exclusion criteria

  • central endothelial cell count less than 2000 cells/mm2
  • glaucoma or intraocular pressure greater than 21 mmHg
  • amblyopia
  • retinal abnormalities
  • diabetes mellitus
  • steroid or immunosuppressive treatment
  • connective tissue diseases

Treatment and study plan

Multifocal IOL implantation + Vitrectomy

Procedure

25-gauge transconjuntival sutureless vitrectomy (TSV)

Other names: VITRECTOMY

Multifocal IOL implantation - Vitrectomy

Procedure

Multifocal IOL implantation without transconjunctival vitrectomy

Primary outcomes

  1. The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Hospital Oftalmologico de Brasilia

Other

Collaborators

  • Federal University of Minas Gerais

Registry information

Official study title

Transconjunctival Sutureless 25-Gauge Vitrectomy for Visually Significant Vitreous Floaters in Patients With Multifocal Intraocular Lens

Acronym: TSV-25G

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Mar 27, 2009
Registry last updated
Mar 27, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.